Federal contract award
75N98C25P00058
THIS QIAGEN SOFTWARE IS NECESSARY TO ANALYZE EXOME SEQUENCED DATA FROM HUMAN DEAF FAMILIES WHICH WERE ASCERTAINED BEFORE 2023. IT IS ESSENTIAL TO SUPPORT ONGOING DATA ANALYSES, TO IDENTIFY THE GENETIC CAUSE OF THEIR DISORDER.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INTITUTES OF HEALTH NIDCD |
| NAICS | 513210 — Software Publishers |
| PSC | 7A20 — Application development software delivered by perpetual license, consisting of analysis, design, development, code, test and release packages associated with application development projects. |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $10.9K |
| Current contract value | $10.9K |
| Potential contract value / ceiling | $10.9K |
| Start date | May 2, 2025 |
| Current end date | May 1, 2026 |
| Potential end date | May 1, 2026 |
| Latest award activity | May 6, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 6, 2025 | 0 | $10.9K | THIS QIAGEN SOFTWARE IS NECESSARY TO ANALYZE EXOME SEQUENCED DATA FROM HUMAN DEAF FAMILIES WHICH WERE ASCERTAINED BEFORE 2023. IT IS ESSENTIAL TO SUPPORT ONGOING DATA ANALYSES, TO IDENTIFY THE GENETIC CAUSE OF THEIR DISORDER. |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.